Report Detail

Request for Sample of this report

Medical Industry Global Infection Control in Cancer Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM2953077
    • |
  • 15 February, 2019
    • |
  • Global
    • |
  • 136 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Medical Industry

The Preventing Infections in Cancer Patients campaign provides resources to help lower the risk of cancer patients developing potentially life-threatening infections during chemotherapy treatment.

Scope of the Report:

The global Infection Control in Cancer Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Infection Control in Cancer Therapy.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Infection Control in Cancer Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Infection Control in Cancer Therapy market by product type and applications/end industries.

Market Segment by Companies, this report covers

    Kimberly Clark Corporation

    3M Healthcare Company

    Honeywell International, Inc.

    Getinge Group AB

    Sterigenics International

    Sakura Global Holding Company

    Arizant Healthcare Inc.

    Nordion

    Cisa S.P.A.

    Steris Corporation

    Nordion, Inc.

    Ahlstrom Filtration LLC

    Membrana GmbH

    Synergy Health, Plc

    Advanced Sterilization Products Services, Inc

Market Segment by Regions, regional analysis covers 

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

    Radiation Therapy

    Immunotherapy

    Traditional Surgery

    Stem Cell Transplant Therapy

    Chemotherapy

    Targeted Therapy

    Photodynamic Therapy

    Other

Market Segment by Applications, can be divided into

    Hospital

    Pharmaceutical Companies

    Medical device companies

    Other

 

 


Table of Contents

    1 Infection Control in Cancer Therapy Market Overview

    • 1.1 Product Overview and Scope of Infection Control in Cancer Therapy
    • 1.2 Classification of Infection Control in Cancer Therapy by Types
    • 1.2.1 Global Infection Control in Cancer Therapy Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Infection Control in Cancer Therapy Revenue Market Share by Types in 2018
  • 1.2.3 Radiation Therapy
  • 1.2.4 Immunotherapy
  • 1.2.5 Traditional Surgery
  • 1.2.6 Stem Cell Transplant Therapy
  • 1.2.7 Chemotherapy
  • 1.2.8 Targeted Therapy
  • 1.2.9 Photodynamic Therapy
  • 1.2.10 Other
  • 1.3 Global Infection Control in Cancer Therapy Market by Application
  • 1.3.1 Global Infection Control in Cancer Therapy Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospital
  • 1.3.3 Pharmaceutical Companies
  • 1.3.4 Medical device companies
  • 1.3.5 Other
  • 1.4 Global Infection Control in Cancer Therapy Market by Regions
  • 1.4.1 Global Infection Control in Cancer Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Infection Control in Cancer Therapy Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Infection Control in Cancer Therapy Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Infection Control in Cancer Therapy Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Infection Control in Cancer Therapy Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Infection Control in Cancer Therapy Status and Prospect (2014-2024)
  • 1.5 Global Market Size of Infection Control in Cancer Therapy (2014-2024)

    • 2 Manufacturers Profiles

    • 2.1 Kimberly Clark Corporation
    • 2.1.1 Business Overview
  • 2.1.2 Infection Control in Cancer Therapy Type and Applications
  • 2.1.2.1 Product A
  • 2.1.2.2 Product B
  • 2.1.3 Kimberly Clark Corporation Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
  • 2.2 3M Healthcare Company
  • 2.2.1 Business Overview
  • 2.2.2 Infection Control in Cancer Therapy Type and Applications
  • 2.2.2.1 Product A
  • 2.2.2.2 Product B
  • 2.2.3 3M Healthcare Company Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
  • 2.3 Honeywell International, Inc.
  • 2.3.1 Business Overview
  • 2.3.2 Infection Control in Cancer Therapy Type and Applications
  • 2.3.2.1 Product A
  • 2.3.2.2 Product B
  • 2.3.3 Honeywell International, Inc. Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
  • 2.4 Getinge Group AB
  • 2.4.1 Business Overview
  • 2.4.2 Infection Control in Cancer Therapy Type and Applications
  • 2.4.2.1 Product A
  • 2.4.2.2 Product B
  • 2.4.3 Getinge Group AB Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
  • 2.5 Sterigenics International
  • 2.5.1 Business Overview
  • 2.5.2 Infection Control in Cancer Therapy Type and Applications
  • 2.5.2.1 Product A
  • 2.5.2.2 Product B
  • 2.5.3 Sterigenics International Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
  • 2.6 Sakura Global Holding Company
  • 2.6.1 Business Overview
  • 2.6.2 Infection Control in Cancer Therapy Type and Applications
  • 2.6.2.1 Product A
  • 2.6.2.2 Product B
  • 2.6.3 Sakura Global Holding Company Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
  • 2.7 Arizant Healthcare Inc.
  • 2.7.1 Business Overview
  • 2.7.2 Infection Control in Cancer Therapy Type and Applications
  • 2.7.2.1 Product A
  • 2.7.2.2 Product B
  • 2.7.3 Arizant Healthcare Inc. Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
  • 2.8 Nordion
  • 2.8.1 Business Overview
  • 2.8.2 Infection Control in Cancer Therapy Type and Applications
  • 2.8.2.1 Product A
  • 2.8.2.2 Product B
  • 2.8.3 Nordion Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
  • 2.9 Cisa S.P.A.
  • 2.9.1 Business Overview
  • 2.9.2 Infection Control in Cancer Therapy Type and Applications
  • 2.9.2.1 Product A
  • 2.9.2.2 Product B
  • 2.9.3 Cisa S.P.A. Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
  • 2.10 Steris Corporation
  • 2.10.1 Business Overview
  • 2.10.2 Infection Control in Cancer Therapy Type and Applications
  • 2.10.2.1 Product A
  • 2.10.2.2 Product B
  • 2.10.3 Steris Corporation Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
  • 2.11 Nordion, Inc.
  • 2.11.1 Business Overview
  • 2.11.2 Infection Control in Cancer Therapy Type and Applications
  • 2.11.2.1 Product A
  • 2.11.2.2 Product B
  • 2.11.3 Nordion, Inc. Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
  • 2.12 Ahlstrom Filtration LLC
  • 2.12.1 Business Overview
  • 2.12.2 Infection Control in Cancer Therapy Type and Applications
  • 2.12.2.1 Product A
  • 2.12.2.2 Product B
  • 2.12.3 Ahlstrom Filtration LLC Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
  • 2.13 Membrana GmbH
  • 2.13.1 Business Overview
  • 2.13.2 Infection Control in Cancer Therapy Type and Applications
  • 2.13.2.1 Product A
  • 2.13.2.2 Product B
  • 2.13.3 Membrana GmbH Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
  • 2.14 Synergy Health, Plc
  • 2.14.1 Business Overview
  • 2.14.2 Infection Control in Cancer Therapy Type and Applications
  • 2.14.2.1 Product A
  • 2.14.2.2 Product B
  • 2.14.3 Synergy Health, Plc Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
  • 2.15 Advanced Sterilization Products Services, Inc
  • 2.15.1 Business Overview
  • 2.15.2 Infection Control in Cancer Therapy Type and Applications
  • 2.15.2.1 Product A
  • 2.15.2.2 Product B
  • 2.15.3 Advanced Sterilization Products Services, Inc Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)

    • 3 Global Infection Control in Cancer Therapy Market Competition, by Players

    • 3.1 Global Infection Control in Cancer Therapy Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
    • 3.2.1 Top 5 Infection Control in Cancer Therapy Players Market Share
  • 3.2.2 Top 10 Infection Control in Cancer Therapy Players Market Share
  • 3.3 Market Competition Trend

    • 4 Global Infection Control in Cancer Therapy Market Size by Regions

    • 4.1 Global Infection Control in Cancer Therapy Revenue and Market Share by Regions
    • 4.2 North America Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)
    • 4.5 South America Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)

    5 North America Infection Control in Cancer Therapy Revenue by Countries

    • 5.1 North America Infection Control in Cancer Therapy Revenue by Countries (2014-2019)
    • 5.2 USA Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)

    6 Europe Infection Control in Cancer Therapy Revenue by Countries

    • 6.1 Europe Infection Control in Cancer Therapy Revenue by Countries (2014-2019)
    • 6.2 Germany Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)
    • 6.3 UK Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)
    • 6.4 France Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Infection Control in Cancer Therapy Revenue by Countries

    • 7.1 Asia-Pacific Infection Control in Cancer Therapy Revenue by Countries (2014-2019)
    • 7.2 China Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)
    • 7.5 India Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)

    8 South America Infection Control in Cancer Therapy Revenue by Countries

    • 8.1 South America Infection Control in Cancer Therapy Revenue by Countries (2014-2019)
    • 8.2 Brazil Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Infection Control in Cancer Therapy by Countries

    • 9.1 Middle East and Africa Infection Control in Cancer Therapy Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Infection Control in Cancer Therapy Revenue and Growth Rate (2014-2019)

    10 Global Infection Control in Cancer Therapy Market Segment by Type

    • 10.1 Global Infection Control in Cancer Therapy Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Infection Control in Cancer Therapy Market Forecast by Type (2019-2024)
    • 10.3 Radiation Therapy Revenue Growth Rate (2014-2024)
    • 10.4 Immunotherapy Revenue Growth Rate (2014-2024)
    • 10.5 Traditional Surgery Revenue Growth Rate (2014-2024)
    • 10.6 Stem Cell Transplant Therapy Revenue Growth Rate (2014-2024)
    • 10.7 Chemotherapy Revenue Growth Rate (2014-2024)
    • 10.8 Targeted Therapy Revenue Growth Rate (2014-2024)
    • 10.9 Photodynamic Therapy Revenue Growth Rate (2014-2024)
    • 10.10 Other Revenue Growth Rate (2014-2024)

    11 Global Infection Control in Cancer Therapy Market Segment by Application

    • 11.1 Global Infection Control in Cancer Therapy Revenue Market Share by Application (2014-2019)
    • 11.2 Infection Control in Cancer Therapy Market Forecast by Application (2019-2024)
    • 11.3 Hospital Revenue Growth (2014-2019)
    • 11.4 Pharmaceutical Companies Revenue Growth (2014-2019)
    • 11.5 Medical device companies Revenue Growth (2014-2019)
    • 11.6 Other Revenue Growth (2014-2019)

    12 Global Infection Control in Cancer Therapy Market Size Forecast (2019-2024)

    • 12.1 Global Infection Control in Cancer Therapy Market Size Forecast (2019-2024)
    • 12.2 Global Infection Control in Cancer Therapy Market Forecast by Regions (2019-2024)
    • 12.3 North America Infection Control in Cancer Therapy Revenue Market Forecast (2019-2024)
    • 12.4 Europe Infection Control in Cancer Therapy Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Infection Control in Cancer Therapy Revenue Market Forecast (2019-2024)
    • 12.6 South America Infection Control in Cancer Therapy Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Infection Control in Cancer Therapy Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology
      • 14.2 Data Source

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$4,680.00
      		2,690.04
      		3,617.64
      		3,239.88
      		4,357.08
      		531,361.20
      		714,589.20
      		293,712.00
      		394,992.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo